BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 235 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $5,933,912 | +73348.6% | 960,180 | -39.6% | 0.01% | -23.1% |
| Q1 2024 | $8,079 | -23.1% | 1,590,380 | -9.4% | 0.01% | -18.8% |
| Q4 2023 | $10,512 | +635.6% | 1,754,980 | +769.5% | 0.02% | +700.0% |
| Q3 2023 | $1,429 | -100.0% | 201,845 | -64.3% | 0.00% | -80.0% |
| Q3 2022 | $7,124,000 | +432.4% | 565,380 | +347.0% | 0.01% | +400.0% |
| Q2 2022 | $1,338,000 | -67.3% | 126,480 | -49.7% | 0.00% | -60.0% |
| Q1 2022 | $4,089,000 | -30.3% | 251,480 | -38.4% | 0.01% | -37.5% |
| Q3 2021 | $5,866,000 | -64.1% | 408,180 | -60.5% | 0.01% | -60.0% |
| Q2 2021 | $16,324,000 | +2279.6% | 1,032,480 | +1430.3% | 0.02% | +1900.0% |
| Q1 2021 | $686,000 | -92.8% | 67,470 | -94.7% | 0.00% | -90.0% |
| Q4 2020 | $9,539,000 | +228.8% | 1,280,380 | +52.3% | 0.01% | +400.0% |
| Q4 2019 | $2,901,000 | +380.3% | 840,734 | +298.8% | 0.00% | +100.0% |
| Q3 2019 | $604,000 | -63.5% | 210,815 | -2.9% | 0.00% | -50.0% |
| Q3 2018 | $1,657,000 | -72.0% | 217,203 | -81.3% | 0.00% | -33.3% |
| Q2 2018 | $5,923,000 | +61.7% | 1,162,384 | +51.4% | 0.00% | -25.0% |
| Q1 2018 | $3,662,000 | +88.3% | 767,803 | +93.8% | 0.00% | +100.0% |
| Q4 2017 | $1,945,000 | +63.9% | 396,203 | +74.9% | 0.00% | +100.0% |
| Q3 2017 | $1,187,000 | -47.2% | 226,503 | -44.0% | 0.00% | -66.7% |
| Q2 2017 | $2,249,000 | +22.2% | 404,503 | +84.5% | 0.00% | 0.0% |
| Q1 2017 | $1,841,000 | +482.6% | 219,203 | +339.3% | 0.00% | – |
| Q4 2016 | $316,000 | -61.8% | 49,903 | -82.9% | 0.00% | -100.0% |
| Q1 2016 | $827,000 | -43.9% | 292,221 | +104.5% | 0.00% | -33.3% |
| Q4 2015 | $1,475,000 | +403.4% | 142,903 | +341.0% | 0.00% | +200.0% |
| Q1 2015 | $293,000 | -69.4% | 32,403 | -64.2% | 0.00% | -50.0% |
| Q1 2014 | $958,000 | – | 90,514 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 3,846,154 | $40,692,000 | 16.07% |
| Fairmount Funds Management LLC | 3,343,107 | $35,370,000 | 8.10% |
| Kynam Capital Management, LP | 936,563 | $9,909,000 | 2.53% |
| Velan Capital Investment Management LP | 225,000 | $2,381,000 | 2.42% |
| ORACLE INVESTMENT MANAGEMENT INC | 603,994 | $6,390,000 | 1.94% |
| TANG CAPITAL MANAGEMENT LLC | 1,200,000 | $12,696,000 | 1.93% |
| MPM BioImpact LLC | 639,089 | $6,762,000 | 1.88% |
| Ghost Tree Capital, LLC | 325,000 | $3,439,000 | 1.79% |
| Sarissa Capital Management LP | 1,390,790 | $14,715,000 | 1.48% |
| Prosight Management, LP | 176,680 | $1,869,000 | 1.47% |